ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "functional status"

  • Abstract Number: 0899 • ACR Convergence 2022

    Performance of the Foot Function Index Questionnaire in Patients with Rheumatoid Arthritis

    Joan Manuel Dapeña, Lucia Alascio, Eliana Rebeca Serrano, Juan Manuel Bande, Maria Alejandra Medina, Diana Silvia Klajn, Jose Angel Caracciolo and Silvia Beatriz Papasidero, Hospital General de Agudos Dr. Enrique Tornu, Buenos Aires, Argentina

    Background/Purpose: Multiple questionnaires and objective assessment tools have been developed to determine functional compromise in Rheumatoid Arthritis (RA). One of the most used tools to…
  • Abstract Number: 1013 • ACR Convergence 2022

    Discriminatory Capacity of the ASAS Health Index in Patients with Axial Spondyloarthritis Treated in a Tight Control Setting versus Standard of Care

    Uta Kiltz1, Anna Molto2, Clementina Lopez-Medina3, Maxime Dougados4, Désirée van der Heijde5, Annelies Boonen6, Filip Van den bosch7 and Juergen Braun1, 1Rheumazentrum Ruhrgebiet, Herne, Germany, 2Rheumatology Department, Cochin Hospital, APHP, Paris, France, 3Reina Sofia University Hospital, Rheumatology Department, Jaén, Spain, 4Department of Rheumatology, Hôpital Cochin, Paris, France, Paris, France, 5Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands, Leiden, Netherlands, 6Maastricht University Medical Centre, Maastricht, Netherlands, 7Department of Internal Medicine and Paediatrics, Ghent University and VIB Centre for Inflammation Research, Ghent, Belgium

    Background/Purpose: Improvement in functioning and health as assessed by the ASAS Health Index (HI) is an important outcome of interventions in patients with axial spondyloarthritis…
  • Abstract Number: 1330 • ACR Convergence 2022

    Impact of COVID-19 Severity on Physical Function, Mobility, Falls and Fractures Among Older Patients After Hospitalization: A Longitudinal Study

    Clara Wong1, Diego Cabrera2, Mary Geda3, Andrew Cohen3, Lauren Ferrante3, Alexandra Hajduk3 and Evelyn Hsieh2, 1Yale School of Public Health, New Haven, CT, 2Section of Rheumatology, Allergy and Immunology, Yale School of Medicine, New Haven, CT, 3Yale School of Medicine, New Haven, CT

    Background/Purpose: No longitudinal studies have examined the impact of COVID-19 or COVID-19 severity on physical function and disability outcomes among older adults. Multiple factors, including…
  • Abstract Number: 0366 • ACR Convergence 2021

    Why Is It so Difficult for AxSpA Patients to Find a Job? Results from the European Map of Axial Spondyloarthritis (EMAS)

    Marco Garrido-Cumbrera1, Victoria Navarro-Compán2, Christine Bundy3, Souzi Makri4, Laura Christen5, José Correa-Fernández6, Sergio Sanz-Gomez6, Raj Mahapatra7, Carlos Jesús Delgado-Domínguez6 and Denis Poddubnyy8, 1Health & Territory Research (HTR), University of Seville, Sevilla, Spain, 2Rheumatology service, Hospital Universitario La Paz-IdiPaz, Madrid, Spain, 3Cardiff University, Cardiff, Wales, United Kingdom, 4Cyprus League Against Rheumatism (CYPLAR), Limassol, Cyprus, 5Novartis Pharma AG, Basel, Switzerland, 6Health & Territory Research (HTR), Universidad de Sevilla, Seville, Spain, 7Axial Spondyloarthritis International Federation (ASIF), London, United Kingdom, 8Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany

    Background/Purpose: AxSpA is associated with substantial negative consequences regarding work status and career prospects. The aim is to identify factors associated with barriers to job…
  • Abstract Number: 0633 • ACR Convergence 2021

    Value of the Routine Assessment of Patient Index Data 3 (RAPID3) as a Disease Activity Measure in Patients with Psoriatic Arthritis

    Johny Fares1, Andrea Healy1 and Martin Bergman2, 1Main Line Health, Wynnewood, PA, 2Martin Jan Bergman, MD, Ridley Park, PA

    Background/Purpose: The RAPID3 is a patient-reported pooled index of three measures: function, pain, and patient global estimate of status, that is used to classify disease…
  • Abstract Number: 0634 • ACR Convergence 2021

    Correlation Between the Functional Component of the Multidimensional Health Assessment Questionnaire (FN), Modified Health Assessment Questionnaire (MHAQ), Health Assessment Questionnaire II (HAQ-II) and a Single Functional Question (PF) in Patients with Rheumatic Disease

    Andrea Healy1, Johny Fares1, Martin Bergman2, Kaleb Michaud3, Alison Petro3 and Harlan Sayles3, 1Main Line Health, Wynnewood, PA, 2Martin Jan Bergman, MD, Ridley Park, PA, 3University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: There has been significant work developing questionnaires to find effective and reliable ways of characterizing the functional status of patients, to track disease progression…
  • Abstract Number: 1165 • ACR Convergence 2021

    “What Matters”: Patient and Clinician Perspectives in Psoriatic Arthritis Care

    Philip Mease1, Dan Furst2, Evan Siegel3, Vibeke Strand4, Melissa Mcilraith5, Elaine Husni6 and M. Cameron Hay7, 1Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, 2University of California Los Angeles, Los Angeles, CA, 3Arthritis and Rheumatism Associates, Potomac, MD, 4Stanford University School of Medicine, Portola Valley, CA, 5M.Mc. Consulting, Dallas, TX, 6Cleveland Clinic, Cleveland, OH, 7Miami University (Ohio), Oxford, OH

    Background/Purpose: Recent psoriatic arthritis (PsA) treatment recommendations (1), highlight the importance of shared decision making; this ideally requires the clinician understands “what matters” to each…
  • Abstract Number: 1458 • ACR Convergence 2020

    Slower Current Walking Speed Is Associated with Progression in Radiographic Knee Osteoarthritis: The Johnston County Osteoarthritis Project

    Lindsey Duca1, Liubov Arbeeva2, Yvonne Golightly3, Louise Murphy4, Charles Helmick4 and Kamil Barbour5, 1Centers for Disease Control and Prevention, Chamblee, GA, 2University of North Carolina at Chapel Hill Thurston Arthritis Research Center, Chapel Hill, NC, 3University of North Carolina at Chapel Hill Dept of Epidemiology, Chapel Hill, NC, 4Centers for Disease Control and Prevention, Atlanta, GA, 5CDC, Atlanta, GA

    Background/Purpose: Poorer physical functioning as a single baseline measurement has been associated with increased risk of radiographic knee osteoarthritis (rKOA) progression, but it is unknown…
  • Abstract Number: 1468 • ACR Convergence 2020

    The Association of Walking Speed from Short- and Standard-Distance Tests with Mortality Risk Among Adults with Radiographic Knee Osteoarthritis: Data from Johnston County Osteoarthritis Project, Osteoarthritis Initiative and Multicenter Osteoarthritis Study

    Hiral Master1, Tuhina Neogi2, Leigh Callahan3, Amanda Nelson4, Michael LaValley5, Rebecca Cleveland6, Yvonne Golightly7, Louise Thoma8, Yuqing Zhang9, Dana Voinier10, Meredith Christiansen11, Jason Jakiela10, Michael Nevitt12, Cora Lewis13, Laura Frey Law14 and Daniel White10, 1Vanderbilt University Medical Center, Nashville, TN, 2Boston University School of Medicine, Boston, MA, 3University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC, 4University of North Carolina Chapel Hill, Chapel Hill, 5Boston University School of Public Health, Boston, MA, 6University of North Carolina, Chapel Hill, NC, 7University of North Carolina at Chapel Hill Dept of Epidemiology, Chapel Hill, NC, 8University of North Carolina at Chapel Hill, Chapel Hill, NC, 9Massachusetts General Hospital, Harvard Medical School, Boston, 10University of Delaware, Newark, DE, 11University of Delaware, New York, NY, 12University of California, San Francisco, San Francisco, CA, 13University of Alabama Birmingham, Birmingham, AL, 14University of Iowa, Iowa City, IA

    Background/Purpose: Patients with radiographic knee OA (rKOA) are at increased risk of mortality and walking difficulty may mediate this relation. Walking speed may be used…
  • Abstract Number: 1657 • ACR Convergence 2020

    Do Comorbidities Limit Improvement in Pain and Physical Function After Total Knee Arthroplasty in Patients with Knee Osteoarthritis?

    Lauren King1, Esther Waugh1, Allyson Jones2, Deborah Marshall3 and Gillian Hawker4, 1University of Toronto, Toronto, Canada, 2University of Alberta, Edmonton, AB, Canada, 3University of Calgary, Calgary, AB, Canada, 4University of Toronto, Toronto, ON, Canada

    Background/Purpose: Individuals with knee osteoarthritis (OA) are increasingly living with multiple comorbid conditions. The presence of comorbidities has been associated with having worse OA symptoms…
  • Abstract Number: 1726 • ACR Convergence 2020

    Assessment of the Components of RAPID3 Patient Reported Outcomes in an Community Rheumatology Practice

    Elston He1, Pratyusha Yalamanchi2, William Arnold3 and Erin Arnold4, 1Synovium, Inc., Philadelphia, PA, 2Michigan Medicine, Ann Arbor, MI, 3Retired, Wilmette, IL, 4Private Practice, Orthopaedics and Rheumatology of the North Shore, Wilmette, IL

    Background/Purpose: Patient reported outcomes are integral to measuring patient response to treatment for rheumatoid arthritis (RA). RAPID3 is a patient reported outcome metric that consists…
  • Abstract Number: 1900 • ACR Convergence 2020

    The Clinical and the Functional Impact of Central Sensitization on Patients with Axial Spondyloarthritis

    Feyza Nur Yücel1 and Mehmet Tuncay Duruöz2, 1Marmara University School of Medicine PMR Department, Istanbul, Turkey, 2Marmara University School of Medicine, PMR Department, Rheumatology Division, Istanbul, Turkey

    Background/Purpose: To evaluate the impact of central sensitization (CS) on axial spondyloarthritis (AxSpA) patients’ clinical and functional situation and quality of life.Methods: Subjects with axSpA…
  • Abstract Number: 0046 • ACR Convergence 2020

    Socioeconomic Disparities in Functional Status Among RA Patients: A Longitudinal Analysis Using RISE Data

    Jing Li1, Gabriela Schmajuk2, Michael Evans3, Zara Izadi4, Patricia Katz5, Alexis Ogdie6, Lisa Suter7 and Jinoos Yazdany3, 1University of California, San Francisco, San Francisco, CA, 2University of California, San Francisco, Atherton, CA, 3Ucsf, San Francisco, CA, 4University of California San Francisco, San Francisco, CA, 5University of California, San Francisco, Novato, CA, 6Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 7Yale School of Medicine, New Haven, CT

    Background/Purpose: Prior studies have shown that RA outcomes, including disease activity, erosions, and disability, are worse among patients with low socioeconomic status (SES). However, few…
  • Abstract Number: 0337 • ACR Convergence 2020

    Similar Impact of Psoriatic Arthritis and Rheumatoid Arthritis on Objective and Subjective Parameters of Hand Function

    Anna-Maria Liphardt1, Eva Manger2, Sonja Liehr2, Lisa Bieniek2, Arnd Kleyer3, David Simon3, Koray Tascilar3, Michael Sticherling4, Juergen Rech3, Georg Schett5 and Axel Hueber6, 1Friedrich-Alexander-University Erlangen-Nuremberg, Internal Medicine 3 - Rheumatology & Immunology, University Hospital Erlangen, Erlangen, Bayern, Germany, 2Departement of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nuremberg and University Hospital Erlangen, Erlangen, Bayern, Germany, 3Department of Internal Medicine 3, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Bayern, Germany, 4Department of Internal Medicine 3, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, 5Friedrich-Alexander-Universität Erlangen- Nuremberg, Erlangen, Germany, 6Sozialstiftung Bamberg, Sektion Rheumatologie, Bamberg, Germany

    Background/Purpose: To compare the impact of psoriatic arthritis (PsA) and rheumatoid arthritis (RA) on objective and subjective parameters of hand function.Methods: Hand function was assessed…
  • Abstract Number: 0480 • ACR Convergence 2020

    Impact of Targeting Remission or Low Disease Activity on 10-year Severity in Rheumatoid Arthritis : Data from ESPOIR Cohort

    Julia Dupont1, Gregory Guernec2, Yannick Degboé3, Frédéric Lioté4, Olivier Vittecoq5, Arnaud Constantin6 and Adeline Ruyssen Witrand7, 1University Hospital of Thoulouse, Toulouse, 2Inserm UMR 1027, TOULOUSE CEDEX 9, France, 3University Hospital of Toulouse, Toulouse, 4AP-HP, Paris, France, 5University Hospital of Rouen, Rouen, France, 6Rheumatology Department, Toulouse University Hospital, Toulouse, France, 7Rheumatology center, University Hospital of Toulouse, Inserm 1027, University Paul Sabatier, Toulouse, France, Toulouse, France

    Background/Purpose: The aim of rheumatoid arthritis (RA) treatment is to target remission or at least low disease activity (LDA). We previously showed that SDAI remission…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology